![Michelle Morrow](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michelle Morrow
Geen lopende functies
Profiel
Michelle Morrow worked as Chief Scientific Officer at Avacta Group Plc from 2024 to 2026.
Dr. Morrow also worked as Senior VP & Head-Therapeutics Innovation at invoX Pharma Ltd. Dr. Morrow earned a doctorate from the University of Cambridge.
Eerdere bekende functies van Michelle Morrow
| Bedrijven | Functie | Einde |
|---|---|---|
| AVACTA GROUP PLC | Hoofd Techniek/Wetenschap/O&O | 09-02-2026 |
invoX Pharma Ltd.
 invoX Pharma Ltd. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company | Corporate Officer/Principal | - |
Opleiding van Michelle Morrow
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
3
Eerstegraads connecties
3
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Avacta Group Plc
 Avacta Group Plc Miscellaneous Commercial ServicesCommercial Services Engages in the business of healthcare technology and consumables | Commercial Services |
invoX Pharma Ltd.
invoX Pharma Ltd. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company | Health Technology |
